Dr. Sun received his PhD degree from Industrial and Physical Pharmacy at Purdue University in 2016. He joined the College of Pharmacy at the University of Arizona in 2020 after completion of his postdoctoral training in nanomedicine and immunotherapy at the University of North Carolina at Chapel Hill. He published 9 papers in pharmaceutical journals, 1 book chapter and 1 licensed patent.
Dr. Sun’s research aims to exploit the techniques in synthetic chemistry, immunology, medicine and nanotechnology to develop safe and effective therapies for patients with cancer or other life-threatening diseases. He developed nanocrystal formulations for intraperitoneal and systemic chemotherapy during his graduate study. Dr. Sun pursued his interests in immunotherapy in the department of Radiation Oncology at UNC-Chapel Hill. His postdoctoral research was developing nano-formulations of adjuvants and immune checkpoint modulators. His work at U of Arizona focuses on the development of delivery platform of cancer vaccines for immunotherapy.